GoAI
Get started
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

NASDAQHealthcareMedical - Care Facilities

Open in GoAI

Previous close

$12.47

−$0.18 · -1.42%

Aug 21, 4:00 PM ET

Pre-market

$12.45

−$0.02 · -0.16%

Aug 24, 7:07 AM ET

LFST company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

24

Expensive

Momentum

70

Gaining

Sentiment

41

Mixed

Risk resilience

59

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
David Patrick Bourdon
Listed since
Jun 10, 2021
Employees
8,542

Market position

Day range

Current $12.47

52-week range

Current $12.47

Open
$12.65
Previous close
$12.65
Volume
2.62M
0.59× average
Average volume
4.46M
Average daily volume
Market cap
4.84B USD
Beta
1.2
Market reference 1
50-day average
$10.7804
+15.67% above average
200-day average
$7.9137
+57.58% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.66B USD
P/E (TTM)
95.78×
P/B (TTM)
3.24×
P/S (TTM)
3.05×
EV / EBITDA
33.8×
Earnings yield
0.36%
Free cash flow yield
4.05%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
33.56%
Operating margin
4.95%
Net margin
3.19%
Return on equity
0.64%
Return on assets
0.44%
Return on invested capital
0.94%

Financial health

Debt / equity
0.14×
Current ratio
1.65×
Altman Z-score
4.53
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%9%-23%-54%Gross margin, FY2021: 30.19%Gross margin, FY2022: 27.57%Gross margin, FY2023: 28.62%Gross margin, FY2024: 32.17%Gross margin, FY2025: 32.37%Operating margin, FY2021: -42.90%Operating margin, FY2022: -24.45%Operating margin, FY2023: -17.92%Operating margin, FY2024: -2.53%Operating margin, FY2025: 1.70%Net margin, FY2021: -46.02%Net margin, FY2022: -25.08%Net margin, FY2023: -17.64%Net margin, FY2024: -4.59%Net margin, FY2025: 0.68%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 30.19%. Gross margin FY2022 27.57%. Gross margin FY2023 28.62%. Gross margin FY2024 32.17%. Gross margin FY2025 32.37%. Operating margin FY2021 -42.90%. Operating margin FY2022 -24.45%. Operating margin FY2023 -17.92%. Operating margin FY2024 -2.53%. Operating margin FY2025 1.70%. Net margin FY2021 -46.02%. Net margin FY2022 -25.08%. Net margin FY2023 -17.64%. Net margin FY2024 -4.59%. Net margin FY2025 0.68%.

Income trends

Revenue

1.42B USD+13.85%

Operating income

24.15M USD+55.76M USD

Net income

9.66M USD+67.11M USD
Income trends across reported periods1.6B USD904.84M USD212.25M USD−480.35M USDRevenue, FY2021: 667.51M USDRevenue, FY2022: 859.54M USDRevenue, FY2023: 1.06B USDRevenue, FY2024: 1.25B USDRevenue, FY2025: 1.42B USDOperating income, FY2021: −286.35M USDOperating income, FY2022: −210.17M USDOperating income, FY2023: −189.13M USDOperating income, FY2024: −31.61M USDOperating income, FY2025: 24.15M USDNet income, FY2021: −307.2M USDNet income, FY2022: −215.56M USDNet income, FY2023: −186.26M USDNet income, FY2024: −57.44M USDNet income, FY2025: 9.66M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 667.51M USD. Revenue FY2022 859.54M USD. Revenue FY2023 1.06B USD. Revenue FY2024 1.25B USD. Revenue FY2025 1.42B USD. Operating income FY2021 −286.35M USD. Operating income FY2022 −210.17M USD. Operating income FY2023 −189.13M USD. Operating income FY2024 −31.61M USD. Operating income FY2025 24.15M USD. Net income FY2021 −307.2M USD. Net income FY2022 −215.56M USD. Net income FY2023 −186.26M USD. Net income FY2024 −57.44M USD. Net income FY2025 9.66M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.42B USD1.25B USD1.06B USD859.54M USD667.51M USD
Cost of goods sold963.19M USD848.57M USD753.57M USD622.53M USD466M USD
Gross profit461.1M USD402.4M USD302.1M USD237.02M USD201.51M USD
Selling, general, and administrative382.2M USD363.06M USD410.79M USD377.99M USD433.73M USD
Operating expenses436.95M USD434.01M USD491.23M USD447.19M USD487.86M USD
Interest expense11.66M USD26.54M USD21.22M USD19.93M USD38.91M USD
Depreciation and amortization54.75M USD70.95M USD80.44M USD69.2M USD54.14M USD
Operating income24.15M USD−31.61M USD−189.13M USD−210.17M USD−286.35M USD
Net income9.66M USD−57.44M USD−186.26M USD−215.56M USD−307.2M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 1 miss, 0 met estimates
Average EPS surprise
+373.58%
11 comparable reports
Latest EPS result
0.06
Estimate 0.03 · Beat by 83.21%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.10.04-0.02-0.08Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual -0.02, estimate -0.04, surprise +50.00%, Beat. Q2 2025, reported May 7, 2025: actual 0.002, estimate -0.04, surprise +104.62%, Beat. Q3 2025, reported Aug 7, 2025: actual -0.01, estimate -0.03, surprise +66.67%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.003, estimate -0.01, surprise +127.70%, Beat. Q1 2026, reported Feb 25, 2026: actual 0.03, estimate -0.001, surprise +3291.49%, Beat. Q2 2026, reported May 7, 2026: actual 0.04, estimate 0.01, surprise +300.00%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.06, estimate 0.033, surprise +83.21%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.03, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates452.77M400.7M348.64M296.57MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 325.5M USD, estimate 313.98M USD, surprise +3.67%, Beat. Q2 2025, reported May 7, 2025: actual 332.97M USD, estimate 348.71M USD, surprise -4.51%, Miss. Q3 2025, reported Aug 7, 2025: actual 345.31M USD, estimate 358.36M USD, surprise -3.64%, Miss. Q4 2025, reported Nov 6, 2025: actual 363.81M USD, estimate 378.51M USD, surprise -3.88%, Miss. Q1 2026, reported Feb 25, 2026: actual 382.2M USD, estimate 378.42M USD, surprise +1.00%, Beat. Q2 2026, reported May 7, 2026: actual 403.5M USD, estimate 387.46M USD, surprise +4.14%, Beat. Q3 2026, reported Aug 6, 2026: actual 435.35M USD, estimate 414.58M USD, surprise +5.01%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 431.36M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

11 ratings
Strong buy00%
Buy982%
Hold218%
Sell00%
Strong sell00%

Recent analyst actions

9 institutions
Morgan StanleymaintainOverweight

LFST news

zacks.com

LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Read source
zacks.com

5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence

High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.

Read source
zacks.com

LifeStance Health (LFST) Upgraded to Buy: Here's Why

LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read source
zacks.com

LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Read source
prnewswire.com

LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care

One in Three Women Don't Know Perimenopause Can Cause Anxiety, Depression and Mood Changes; Majority Who Seek Mental Healthcare Find It Helpful SCOTTSDALE, Ariz., Aug. 11, 2026 /PRNewswire/ -- A LifeStance Health survey…

Read source
defenseworld.net

LifeStance Health Group (NASDAQ:LFST) Sets New 1-Year High After Analyst Upgrade

LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report)'s stock price reached a new 52-week high during trading on Monday after BTIG Research raised their price target on the stock from $15.00 to $16.00. BTIG…

Read source

LFST peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding LFST

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Small-Cap ETF logoiShares Core S&P Small-Cap ETFIJR
Market value
174.87M
Weight
0.15%
AUM
111.19B USD
Expense ratio
0.06%
Price / 1D
$147.31+0.64%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
70.98M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
62.3M
Weight
0.08%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
51.41M
Weight
0.03%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETF logoVanguard Morningstar Small-Cap Growth ETFVBK
Market value
29.69M
Weight
0.07%
AUM
43.8B USD
Expense ratio
0.05%
Price / 1D
$358.65+0.70%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
27.64M
Weight
0.03%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETF logoState Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Market value
27.23M
Weight
0.16%
AUM
17.03B USD
Expense ratio
0.03%
Price / 1D
$57.28+0.61%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
22.53M
Weight
0.15%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%

Continue in GoAI

Research LFST

research.disclaimer